Cephalexin and Vibramycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin and Vibramycin. Common interactions include acute myocardial infarction among females and cerebral infarction among males.

The phase IV clinical study analyzes what interactions people who take Cephalexin and Vibramycin have. It is created by eHealthMe based on reports of 10 people who take Cephalexin and Vibramycin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 07, 2022

10 people who take Cephalexin and Vibramycin together, and have interactions are studied.


What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 26,030 Cephalexin users for its effectiveness, alternative drugs and more.

What is Vibramycin?

Vibramycin has active ingredients of doxycycline. It is often used in acne. eHealthMe is studying from 1,675 Vibramycin users for its effectiveness, alternative drugs and more.

Number of Cephalexin and Vibramycin reports submitted per year:

Cephalexin and Vibramycin drug interactions.

Common Cephalexin and Vibramycin drug interactions by gender *:

female:

  1. Acute myocardial infarction
  2. Hypothyroidism
  3. Hypoxia
  4. Intestinal ischaemia
  5. Acute prerenal failure
  6. Anaemia
  7. Anxiety
  8. Aortic thrombosis
  9. Aortic valve incompetence
  10. Ascites

male:

  1. Cerebral infarction
  2. Cerebrovascular accident
  3. Chronic kidney disease
  4. Dizziness
  5. Renal failure
  6. Tubulointerstitial nephritis

Common Cephalexin and Vibramycin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Renal failure
  3. Tubulointerstitial nephritis

30-39:

  1. Diabetes mellitus
  2. Gastroenteritis

40-49:

  1. Nephrogenic systemic fibrosis

50-59:

n/a

60+:

  1. Back pain
  2. Hypertension
  3. Ascites
  4. Asthenia
  5. Atrial fibrillation
  6. Atrial flutter
  7. Atrioventricular block first degree
  8. Bradycardia
  9. Bronchitis
  10. Cardiac failure congestive

Common conditions people have *:

  1. Cardiac Disorder: 2 people, 20.00%
  2. Depression: 2 people, 20.00%
  3. Pain: 2 people, 20.00%
  4. Insomnia (sleeplessness): 2 people, 20.00%
  5. Weakness: 1 person, 10.00%
  6. Localised Oedema (fluid retention in a particular part of the body): 1 person, 10.00%
  7. Constipation: 1 person, 10.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 10.00%
  9. Gout (uric acid crystals building up in the body): 1 person, 10.00%
  10. Headache (pain in head): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Vibramycin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cephalexin and Vibramycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cephalexin interactions:

Browse all interactions between Cephalexin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vibramycin interactions:

Browse all interactions between Vibramycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cephalexin and doxycycline (the active ingredients of Cephalexin and Vibramycin, respectively), and Cephalexin and Vibramycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cephalexin and Vibramycin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: